1,567
edits
APROCCHSS: Difference between revisions
Jump to navigation
Jump to search
→Design
(→Design) |
|||
| Line 53: | Line 53: | ||
** Hydrocortisone plus Fludrocortisone (n = 614) | ** Hydrocortisone plus Fludrocortisone (n = 614) | ||
** Placebo (n=627) | ** Placebo (n=627) | ||
* Setting: | * Setting: 34 centres | ||
* Enrollment: | * Enrollment: 2 Sept 2008 - 23 Dec 2015 | ||
* Mean follow-up: | ** two halts: 25 Oct 2011 to 12 May 2012; 22 Jul 2014 to 7 Oct 2014 | ||
* Analysis: | * Mean follow-up: 180 days | ||
* Analysis: intention to treat | |||
* Primary Outcome: 90-day all-cause mortality | * Primary Outcome: 90-day all-cause mortality | ||